Why the study?
Does multivessel disease impact long-term cause-specific mortality in patients with STEMI treated with reperfusion therapy?
Does multivessel disease impact long-term cause-specific mortality in patients with STEMI treated with reperfusion therapy?
Answers are grounded in this paper and cite their sources.
In STEMI patients treated with reperfusion therapy, multivessel disease independently predicts long-term mortality specifically due to heart failure, rather than sudden death or overall mortality.
Patients with STEMI and MVD have a higher long-term mortality than do patients with non-MVD. MVD is not an independent predictor of long-term total mortality or sudden death. However, MVD is a very strong and independent predictor of long-term death caused by heart failure.
No takes yet. Share an insight, caveat, or question.
Schaaf et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: